These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1178807)

  • 1. Fluphenazine enanthate induced decompensations.
    Van Putten T; Mutalipassi LR
    Psychosomatics; 1975; 16(1):37-40. PubMed ID: 1178807
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenothiazine-induced decompensation.
    Van Putten T; Mutalipassi LR; Malkin MD
    Arch Gen Psychiatry; 1974 Jan; 30(1):102-5. PubMed ID: 4587065
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiparkinsonian agents and fluphenazine decanoate.
    Idzorek S
    Am J Psychiatry; 1976 Jan; 133(1):80-2. PubMed ID: 1247126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the incidence and severity of extrapyramidal side effects with fluphenazine enanthate and fluphenazine decanoate.
    Kane J; Quitkin F; Rifkin A; Klein DF
    Am J Psychiatry; 1978 Dec; 135(12):1539-42. PubMed ID: 717574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate.
    Gelenberg AJ; Doller JC; Schooler NR; Mieske M; Severe J; Mandel MR
    Am J Psychiatry; 1979 Feb; 136(2):217-9. PubMed ID: 367182
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of fluphenazine enanthate in psychotic patients.
    Routsonis KG; Photiadis H
    Curr Ther Res Clin Exp; 1973 Mar; 15(3):92-6. PubMed ID: 4196232
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
    Chouinard G; Annable L; Ross-Chouinard A
    Am J Psychiatry; 1982 Mar; 139(3):312-8. PubMed ID: 6120655
    [No Abstract]   [Full Text] [Related]  

  • 8. Extrapyramidal symptoms in the course of fluphenazine treatment.
    Bastecký J; Vinar O; Taussigová D
    Act Nerv Super (Praha); 1972; 14(2):97-9. PubMed ID: 5040184
    [No Abstract]   [Full Text] [Related]  

  • 9. Side effects of depot fluphenazines.
    Ayd FJ
    Adv Biochem Psychopharmacol; 1974; 9(0):301-9. PubMed ID: 4599435
    [No Abstract]   [Full Text] [Related]  

  • 10. Rigidity, hyperpyrexia and coma following fluphenazine enanthate.
    Meltzer HY
    Psychopharmacologia; 1973; 29(4):337-46. PubMed ID: 4707025
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine.
    Granato JE; Stern BJ; Ringel A; Karim AH; Krumholz A; Coyle J; Adler S
    Ann Neurol; 1983 Jul; 14(1):89-90. PubMed ID: 6614876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the neuroleptic malignant syndrome with bromocriptine.
    Dhib-Jalbut S; Hesselbrock R; Brott T; Silbergeld D
    JAMA; 1983 Jul 22-29; 250(4):484-5. PubMed ID: 6134848
    [No Abstract]   [Full Text] [Related]  

  • 13. Patients at risk of developing severe side effects from depot fluphenazine treatment.
    Blum A
    Am J Psychiatry; 1980 Feb; 137(2):254-5. PubMed ID: 7352591
    [No Abstract]   [Full Text] [Related]  

  • 14. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
    Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN
    Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrapyramidal reaction to fluphenazine potentiated by thyrotoxicosis.
    Witschy JK; Redmond FC
    Am J Psychiatry; 1981 Feb; 138(2):246-7. PubMed ID: 7457650
    [No Abstract]   [Full Text] [Related]  

  • 16. Delayed severe extrapyramidal disturbance following frequent depot phenothiazine administration.
    Warner AM; Wyman SM
    Am J Psychiatry; 1975 Jul; 132(7):743-5. PubMed ID: 1137022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism.
    Mindham RH; Gaind R; Anstee BH; Rimmer L
    Psychol Med; 1972 Nov; 2(4):406-13. PubMed ID: 4571143
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics. II. Rating scale data [proceedings].
    Rifkin A; Quitkin F; Kane J; Klein DF
    Psychopharmacol Bull; 1977 Apr; 13(2):49-50. PubMed ID: 323910
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prognostic significance of selected side effects occurring in the course of prolonged-action fluphenazine treatment].
    Koślacz A; Popkowska N; Kulesza E; Lysikowska-Prokop L; Marmurowska-Michalowska H; Perzyński J
    Psychiatr Pol; 1977; 11(2):159-64. PubMed ID: 887674
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged fever without extrapyramidal symptoms during neuroleptic treatment.
    Keshavan MS; Kambhampati RK
    J Clin Psychopharmacol; 1989 Jun; 9(3):230-1. PubMed ID: 2738187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.